- Home
- PNBK vs APVO Comparison
PNBK vs APVO Comparison
Compare PNBK & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNBK
- APVO
- Stock Information
- Founded
- PNBK 1999
- APVO 2016
- Country
- PNBK United States
- APVO United States
- Employees
- PNBK N/A
- APVO N/A
- Industry
- PNBK Major Banks
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- PNBK Finance
- APVO Health Care
- Exchange
- PNBK Nasdaq
- APVO Nasdaq
- Market Cap
- PNBK 4.3M
- APVO 4.1M
- IPO Year
- PNBK N/A
- APVO N/A
- Fundamental
- Price
- PNBK $5.72
- APVO $0.32
- Analyst Decision
- PNBK
- APVO Strong Buy
- Analyst Count
- PNBK 0
- APVO 1
- Target Price
- PNBK N/A
- APVO $296.00
- AVG Volume (30 Days)
- PNBK 273.9K
- APVO 3.7M
- Earning Date
- PNBK 05-27-2025
- APVO 05-14-2025
- Dividend Yield
- PNBK N/A
- APVO N/A
- EPS Growth
- PNBK N/A
- APVO N/A
- EPS
- PNBK N/A
- APVO N/A
- Revenue
- PNBK $14,940,000.00
- APVO N/A
- Revenue This Year
- PNBK N/A
- APVO N/A
- Revenue Next Year
- PNBK N/A
- APVO N/A
- P/E Ratio
- PNBK N/A
- APVO N/A
- Revenue Growth
- PNBK N/A
- APVO N/A
- 52 Week Low
- PNBK $0.99
- APVO $0.35
- 52 Week High
- PNBK $4.40
- APVO $38.48
- Technical
- Relative Strength Index (RSI)
- PNBK 64.85
- APVO 24.10
- Support Level
- PNBK $4.06
- APVO $0.60
- Resistance Level
- PNBK $7.47
- APVO $0.35
- Average True Range (ATR)
- PNBK 0.92
- APVO 0.04
- MACD
- PNBK 0.15
- APVO 0.05
- Stochastic Oscillator
- PNBK 61.71
- APVO 3.06
About PNBK Patriot National Bancorp Inc.
Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.